News Archive

Date: 08/30/2012
The Center for the Discovery of New Medicines (CDNM) will coordinate and support work in a range of departments and schools to streamline drug discovery and development, support the translation of early research toward patient use -- a gray area where funding is scarce -- and fully leverage the technical capabilities and intellectual resources at U-M in service of discovering the therapies of tomorrow.
Date: 08/28/2012
MidMichigan Health and the University of Michigan Health System have announced plans to affiliate as clinical and business partners, allowing for a collaboration on the development of a major regional cancer center treating the vast array of cancer diagnoses.
Date: 08/24/2012
The American Cancer Society Cancer Action Network (ACS CAN), the American Cancer Society Great Lakes Division and the University of Michigan Comprehensive Cancer Center (UMCCC) briefed members of Michigan's congressional delegation today in Ann Arbor to encourage sustained federal funding for cancer research.
Date: 08/23/2012
A research study led by Maha Hussain, MD, associate director of clinical research at the University of Michigan Comprehensive Cancer Center has found that the survival rate for African American men is now comparable to caucasians when it comes to prostate cancer.
Date: 08/16/2012
As a key step toward providing patients with treatments based on their own DNA profiles, the University of Michigan and the International Genomics Consortium (IGC) have launched a new joint venture, Paradigm, that will help usher in an age of personalized medicine.
Date: 08/07/2012
Translational Oncology Program at the Univesity of Michigan Comprehensive Cancer Center, led by Diane Simeone, MD, unites cancer researchers across campus to develop new treatment options for patients.
Date: 07/25/2012
Researchers at the University of Michigan Comprehensive Cancer Center have found that a cancer gene linked to aggressive spread of the disease promotes breast cancer stem cells. The finding implies a new way to target the behavior of these lethal cells.
Date: 07/19/2012
Researchers at the University of Michigan Comprehensive Cancer Center, led by Max Wicha, MD, have discovered breast cancer cells with the HER2 marker turn on a cellular pathway that makes them resistant to Herceptin over time.
Date: 07/16/2012
U-M earns a spot on national U.S. News Honor Roll for 18th straight year, comes out on top of new state ranking.
Date: 07/16/2012
A new study lead by University of Michigan Comprehensive Cancer Center researchers, led by lead author Bradley Zebrack, Ph.D., MSW, MPH; shows significant proportions of adolescents and young adult cancer patients are not getting their care needs met.